Project Grant K23AG084893
Award Date
8/15/24
Completion Date
5/31/29
Dollars Obligated
$191K
Federal Agency
National Institute on Aging
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
Charlottesville, VA, USA
Similar Awards
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) is focused on investigating the mechanisms underlying neuronal hyperexcitability and sex differences in Alzheimer's disease (AD). The $249,433 award, effective September 15, 2024 through June 30, 2026, will be carried out by the University of Illinois. The project aims to leverage biophysically-informed computational modeling and experimental data from mouse models to better understand the role...
This $682,000 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) to The Roskamp Institute, Inc. will investigate the influence of microglial cell depletion and repopulation on aducanumab-induced amyloid-related imaging abnormalities (ARIA) and vascular lesions in APOE4 carriers with Alzheimer's disease (AD). The goal is to reveal whether activated microglia-mediated cerebrovascular inflammation contributes to APOE4-mediated ARIA events following aducanumab...
This $528,876 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) will enable Emory University to investigate the cis- and trans-genetic regulation of brain transcriptomics and proteomics associated with Alzheimer's disease and Alzheimer's disease related dementias (AD/ADRD). The key products and services to be delivered include: Developing new analytical tools to integrate transcriptome-wide association studies (TWAS) and proteome-wide association studies...
This Project Grant award of $431,750 from the National Institute on Aging's Aging Research program (CFDA 93.866) will support research to investigate the interaction between biological sex and APOE genotype in modulating Alzheimer's disease (AD) risk. The research will leverage human induced pluripotent stem cell lines with various APOE genotypes and sex chromosome complements to examine how APOE and sex influence amyloid-beta processing, tau hyperphosphorylation, and transcriptional changes...
This $107,948 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) aims to enhance understanding of the biological signatures that distinguish subgroups of patients with Alzheimer's disease (AD). The key goals are to: Determine if AD subtypes can be identified solely using magnetic resonance imaging (MRI)-derived features through the application of machine learning algorithms. Integrate epigenetic profiles, including small non-coding RNA expression and DNA...
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $679,475 to the Regents of the University of Michigan to conduct a national study on the use of antiepileptic medications among patients with dementia in long-term care facilities. The objectives are to: 1) characterize patient, provider, and facility factors associated with antiepileptic prescribing, 2) examine clinical outcomes like mortality and changes in behavioral/pain scores...
This $372,690 project grant awarded by the National Institute on Aging (CFDA 93.866 - Aging Research) aims to comprehensively understand the heterogeneous causal pathophysiology of Alzheimer's disease (AD). The principal investigators at the University of California, Berkeley will develop novel statistical methods to uncover how amyloid-beta, tau accumulation, and cognition are causally related in different subpopulations of AD patients. This insight is expected to reveal optimal treatment...
This federal Project Grant award, valued at $972,000.00 and awarded by the National Institute on Aging (CFDA 93.866 - Aging Research), aims to characterize the genetic architecture underlying the onset of amyloid positivity in Alzheimer's disease (AD). The principal investigator will leverage advanced imaging and genetic analysis techniques, including artificial intelligence, to estimate the age of amyloid-beta onset from over 16,000 positron emission tomography scans. This research seeks to...
This $1,758,779 federal Project Grant award from the National Institute on Aging's Aging Research program (CFDA 93.866) supports research to assess the vulnerability of specific neurons in the entorhinal cortex region due to Alzheimer's disease pathology. The grantee, The Winifred Masterson Burke Medical Research Institute, Inc., will use optogenetic and chemogenetic approaches combined with electrophysiology recordings and behavioral assessments in Alzheimer's disease mouse models to...
This $200,323 federal Project Grant award from the National Institute on Aging's Aging Research program (CFDA 93.866) will support research by the University of South Florida to investigate the aggregation of amyloid-beta (Aβ) peptides during metabolic stress and spreading depolarization events in the brain. The project will utilize multiscale modeling, high-resolution microscopy, antibody staining, and paralysis phenotype testing in C. elegans to determine how physiochemical changes...